Related Experiment Video
Updated: Aug 9, 2026

Single Cell Measurement of Dopamine Release with Simultaneous Voltage-clamp and Amperometry
Published on: November 21, 2012
Repeated amphetamine administration decreases D1 dopamine receptor-mediated inhibition of voltage-gated sodium
Jayms D Peterson1, Marina E Wolf, Francis J White
1Department of Physiology, Northwestern University, Chicago, Illinois 60611, USA. j-peterson@northwestern.edu
Abstract:
Adaptations in dopamine (DA) transmission in the prefrontal cortex (PFC) are thought to be critical to the development and persistence of drug addiction. Our previous findings showed that medial PFC (mPFC) neurons in rats treated repeatedly with amphetamine exhibit a decreased inhibitory response to iontophoretically applied DA, demonstrating altered DA receptor transmission. To determine the role postsynaptic DA D1 receptors play in this effect, we used whole-cell patch-clamp recordings of acutely dissociated pyramidal mPFC neurons and inhibition of transient voltage-sensitive sodium current (INaT) as a measure of D1 receptor function. After 3 d of withdrawal, neurons recorded from amphetamine-treated rats (5 mg/kg for 5 d) demonstrated a significant decrease in whole-cell INaT density and in the ability of D1 receptor stimulation to inhibit INaT. Application of a protein kinase A (PKA) inhibitor blocked the ability of D1 receptor activation to inhibit INaT and increased the current density of both groups to similar values. These results suggest that repeated amphetamine exposure results in subsensitivity of the INaT to D1 receptor-mediated inhibition because of a possible increase in basal PKA activity. This adaptation may contribute to perseverative behaviors in animals that self-administer psychostimulants as well as compromised PFC-dependent behaviors in human addicts.
Related Concept Videos
Desensitization and Tachyphylaxis
Several...
Drugs Affecting Neurotransmitter Synthesis
Drugs Affecting Neurotransmitter Release or Uptake
Adrenergic Agonists: Indirect-Acting Agents
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral bioavailability, and...
Neurochemical Transmission: Sites of Drug Action
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids

